These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 28439375)

  • 21. Pachymeningitis and cerebral granuloma in granulomatosis with polyangiitis: is rituximab a promising treatment option?
    Costa C; Santiago T; Espirito-Santo J; Rovisco J; Silva J; Malcata A
    Acta Reumatol Port; 2017; 42(1):82-87. PubMed ID: 28371573
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Let us improve the system of higher medical education].
    Furmenko IP
    Zdravookhr Ross Fed; 1978; (10):37-41. PubMed ID: 706854
    [No Abstract]   [Full Text] [Related]  

  • 23. Rituximab (MABTHERA) and severe polyangiitis. An option for patients informed of the uncertainties.
    Prescrire Int; 2015 Jun; 24(161):145-8. PubMed ID: 26436161
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Successful treatment of large refractory pyoderma gangrenosum-like presentation of granulomatosis with polyangiitis by rituximab.
    Sen M; Dogra S; Rathi M; Sharma A
    Int J Rheum Dis; 2017 Dec; 20(12):2200-2202. PubMed ID: 27126548
    [No Abstract]   [Full Text] [Related]  

  • 25. [Curriculum changes: is it possible to evaluate their outcome?].
    Eika B; Sonne O
    Ugeskr Laeger; 2004 May; 166(21):1983-6. PubMed ID: 15222067
    [No Abstract]   [Full Text] [Related]  

  • 26. [Treatment of ANCA-associated vascularitides].
    Guillevin L; Pagnoux C
    Presse Med; 2007 May; 36(5 Pt 2):922-7. PubMed ID: 17408912
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rituximab therapy for Wegener's granulomatosis refractory to conventional treatment.
    Sánchez-Escuredo A; Núñez R; Ibernón M; Martínez E; López D; Navarro M; Bonet J; Ara J; Romero R
    Nefrologia; 2011; 31(4):502-4. PubMed ID: 21738261
    [No Abstract]   [Full Text] [Related]  

  • 28. Lack of efficacy of rituximab in Wegener's granulomatosis with refractory granulomatous manifestations.
    Aries PM; Hellmich B; Voswinkel J; Both M; Nölle B; Holl-Ulrich K; Lamprecht P; Gross WL
    Ann Rheum Dis; 2006 Jul; 65(7):853-8. PubMed ID: 16269425
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Education research: assessment of neurology resident clinical competencies in the neurology clinic.
    Gotkine M
    Neurology; 2009 Sep; 73(12):998-9; author reply 999. PubMed ID: 19770481
    [No Abstract]   [Full Text] [Related]  

  • 30. Maintaining remission in a patient with vasculitis.
    Flossmann O; Jayne DR
    Nat Clin Pract Rheumatol; 2008 Sep; 4(9):499-504. PubMed ID: 18648340
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Successful treatment of PR3-ANCA positive vasculitis with pancreatitis as the first manifestation with rituximab.
    Çakar M; Yilmaz S; Çinar M
    Int J Rheum Dis; 2017 Dec; 20(12):2209-2210. PubMed ID: 26929047
    [No Abstract]   [Full Text] [Related]  

  • 32. [Practice-based medical education is best for all].
    Braut GS
    Tidsskr Nor Laegeforen; 2003 Aug; 123(16):2239. PubMed ID: 14508541
    [No Abstract]   [Full Text] [Related]  

  • 33. Technology in anesthesia education and evaluation.
    Kalarickal PL
    J Clin Anesth; 2009 May; 21(3):157-8. PubMed ID: 19464606
    [No Abstract]   [Full Text] [Related]  

  • 34. Evidence for the validity of grouped self-assessments in measuring the outcomes of educational programs.
    D'Eon MF; Trinder K
    Eval Health Prof; 2014 Dec; 37(4):457-69. PubMed ID: 23396128
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis: 2-year results of a randomised trial.
    Jones RB; Furuta S; Tervaert JW; Hauser T; Luqmani R; Morgan MD; Peh CA; Savage CO; Segelmark M; Tesar V; van Paassen P; Walsh M; Westman K; Jayne DR;
    Ann Rheum Dis; 2015 Jun; 74(6):1178-82. PubMed ID: 25739829
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Psoriatic arthritis during rituximab treatment of granulomatosis with polyangiitis: a new paradoxical side effect?].
    Aussy A; Girszyn N; Vandhuick T; Marie I; Vittecoq O; Lévesque H; Benhamou Y
    Rev Med Interne; 2015 Jul; 36(7):491-4. PubMed ID: 25554400
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Direct observation in medical education: a review of the literature and evidence for validity.
    Fromme HB; Karani R; Downing SM
    Mt Sinai J Med; 2009 Aug; 76(4):365-71. PubMed ID: 19642150
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Successful use of Rituximab in a patient with recalcitrant multisystemic eosinophilic granulomatosis with polyangiitis.
    Najem CE; Yadav R; Carlson E
    BMJ Case Rep; 2015 May; 2015():. PubMed ID: 25979957
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Getting More Done: Strategies to Increase Scholarly Productivity.
    Schrager S; Sadowski E
    J Grad Med Educ; 2016 Feb; 8(1):10-3. PubMed ID: 26913095
    [No Abstract]   [Full Text] [Related]  

  • 40. Rituximab for eosinophilic granulomatosis with polyangiitis with severe vasculitic neuropathy: Case report and review of current clinical evidence.
    Fanouriakis A; Kougkas N; Vassilopoulos D; Fragouli E; Repa A; Sidiropoulos P
    Semin Arthritis Rheum; 2015 Aug; 45(1):60-6. PubMed ID: 25908179
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.